FerreiraTSReisFAppenzellerS.Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus. Lupus2016;
25: 1369–1376.
2.
StrianoPStrianoSTortoraF, et al.
Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit2005;
11: CR549–53.
3.
MarraAVargasMStrianoPDel GuercioLBuonannoPServilloG.Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses2014;
82: 619–622.
4.
AdhyaZEl AnbariMAnwarSMortimerAMarrNKarimMY.Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Lupus2019;
28: 713–721.
5.
HarjunpääHAsensMLGuentherCFagerholmSC.Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol2019;
10: 1078.
6.
RobinsonJM.Reactive oxygen species in phagocytic leukocytes. Histochem Cell Biol2008;
130: 281–297.
7.
NowakDGWoolardJAminEM.Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci2008;
121: 3487–3495.
8.
HorbinskiCBartynskiWSCarson-WalterEHamiltonRLTanHPChengS.Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol2009;
30: 588–590.
9.
UzrailAHAssafAMAbdallaSS.Correlations of expression levels of a panel of genes (IRF5, STAT4, TNFSF4, MECP2, and TLR7) and cytokine levels (IL-2, IL-6, IL-10, IL-12, IFN-γ, and TNF-α) with systemic lupus erythematosus outcomes in Jordanian patients.Biomed Res Int2019;
2019: 1703842.
10.
BellosIKarageorgiouVKapniasDKaramanliKESiristatidisC.The role of interleukins in preeclampsia: a comprehensive review. Am J Reprod Immunol2018;
80: e13055.
